Keystone Financial Group Gsk PLC Transaction History

Keystone Financial Group

$296 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$42.05 - $47.77 $52,394 - $59,521	-1,246 Reduced 10.46%	10,665 $464,000
Q1 2022 May 13, 2022	SELL	$40.23 - $47.74 $442 - $525	-11 Reduced 0.09%	11,911 $519,000
Q4 2021 Feb 11, 2022	SELL	$38.88 - $45.31 $1,049 - $1,223	-27 Reduced 0.23%	11,922 $526,000
Q3 2021 Nov 12, 2021	BUY	$38.79 - $43.16 $930 - $1,035	24 Added 0.2%	11,949 $457,000
Q2 2021 Aug 13, 2021	BUY	$36.52 - $41.46 $14,900 - $16,915	408 Added 3.54%	11,925 $475,000
Q1 2021 May 11, 2021	BUY	$34.27 - $40.01 $85,572 - $99,904	2,497 Added 27.68%	11,517 $411,000
Q4 2020 Feb 10, 2021	BUY	$34.07 - $39.94 $8,926 - $10,464	262 Added 2.99%	9,020 $332,000
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $19,969 - $22,526	-524 Reduced 5.65%	8,758 $330,000
Q2 2020 Aug 13, 2020	SELL	$37.87 - $43.58 $1,098 - $1,263	-29 Reduced 0.31%	9,282 $379,000
Q1 2020 May 05, 2020	BUY	$32.47 - $48.83 $44,743 - $67,287	1,378 Added 17.37%	9,311 $353,000
Q4 2019 Feb 06, 2020	BUY	$42.0 - $48.25 $420 - $482	10 Added 0.13%	7,933 $373,000
Q3 2019 Nov 07, 2019	BUY	$40.46 - $43.52 $64,210 - $69,066	1,587 Added 25.05%	7,923 $338,000
Q2 2019 Aug 07, 2019	SELL	$39.4 - $42.7 $10,638 - $11,529	-270 Reduced 4.09%	6,336 $254,000
Q1 2019 May 07, 2019	BUY	$38.57 - $42.69 $254,793 - $282,010	6,606 New	6,606 $276,000
Q4 2018 Feb 11, 2019	SELL	$37.8 - $42.69 $223,851 - $252,810	-5,922 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$39.75 - $42.69 $159 - $170	4 Added 0.07%	5,922 $237,000
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $158 - $171	4 Added 0.07%	5,918 $237,000
Q1 2018 May 15, 2018	BUY	$36.18 - $40.15 $11,794 - $13,088	326 Added 5.83%	5,914 $230,000
Q4 2017 Feb 09, 2018	BUY	$35.34 - $41.9 $197,479 - $234,137	5,588	5,588 $209,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Financial Group with notifications on news.

Account